Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+11.4%
5Y CAGR+6.8%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+11.4%/yr
Annual compound
5Y CAGR
+6.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17093000.00 | +30.7% |
| 2024 | 13074000.00 | +4.2% |
| 2023 | 12549150.00 | +1.6% |
| 2022 | 12354000.00 | +1.8% |
| 2021 | 12136900.00 | -1.6% |
| 2020 | 12329000.00 | 0.0% |
| 2019 | 12329000.00 | - |